Agarwal SP, Khanna R, Karmarkar R, Anwer MK, Khar RK (2007).
Shilajit: a review. Phytother Res 2007; 21: 401–405.
Aquino, A.J.A.,Tunega, D., Schaumann, G.E., Haberhauer, G., Gerzabek, M.H., Lischka, H. (2011). The functionality of cation bridges for binding polar groups in soil aggregates. Int. J. Quantum Chem. 111, 1531–1542.
Badaev SA, Gichner T, Pospisil F, Veleminsky J. (1989). Humic acids inhibit the formation but not the mutagenicity of N-methyl-N- nitrosourea. Mutat Res 210:9–13.
Bhishagratna KK. Susruta Samhita. Vol 2. Varanasi, India: Chowkhamba Sanskrit Series Office; Varansi-1; 1998. Chapter XIII.
Carrasco-Gallardo C, Guzman L, Maccioni RB (2012).
Shilajit: a natural phytocomplex with potential precognitive activity. Int J Alzheimers Dis. 2012;2012:674142. doi: 10.1155/2012/674142. Epub 2012 Feb 23.
Chopra RN, Chopra, I.C., Handa,K.L., Kapur,L.D. Chopra’s Indigenous drugs of india 2nd ed. B Calcutta India; K Dhur of academic Publishers. 1958.
Cornejo A, Jimenez JM, Caballero L, Melo F, Maccioni RB (2011). “Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with alzheimer’s disease,” Journal of Alzheimer’s Disease, vol. 27, no. 1, pp. 143–153, 2011.
Dash B. Materia Medica of Ayurveda. New Delhi: B Jain Publishers; 1991.
Dekker J, Medlen CE, inventor (2003). Oxihumic acid and its use in the treatment of the various conditions.
Dekker J, Medlen CE (1999). Fulvic acid and its use in the treatment of various conditions. PTC Patent PCT/1B 99/01567.
Ferrara G, Loffredo E, Simeone R, Senesi N. (2000). Evaluation of antimutagenic and desmutagenic effects of humic and fulvic acids on roof tips of Vicia faba. Environ Toxicol 15:513–517.
Ghosal S (1993).
Shilajit: Its origin and vital significance. In Traditional Medicine, Mukherjee B (ed.). Oxford – IBH: New Delhi, 308–319.
Ghosal S, Lal J, Singh SK ( 1991). The core structure of
Shilajit humus. Soil Biology Biochem 23:673–680.
Hils J, May A, Sperber M, Klocking R, Helbig B, Sprossig M (1986). Inhibition of several strains of influenza virus type A and B by phenolic polymers. Biomed Biochim Acta 45:1173–1179.
Jaiswal AK, Bhattacharya SK (1992). “Effects of
shilajit on memory, anxiety and brain monoamines in rats,” Indian Journal of Pharmacology, vol. 24, pp. 12–17, 1992.
Kalinichev AG, Iskrenova-Tchoukova E, Ahn W-Y, Clark MM, Kirkpatrick RJ (2011). Effects of Ca2+ on supramolecular aggregation of natural organic matter in aqueous solutions: a comparison of molecular modeling approaches. Geoderma 169, 27–32.
Laub RJ. (1999). Process for preparing synthetic soil-extract materials and medicaments based thereon. USA Patent 5,945,446.
Lu FJ, Shih SR, Liu TM, Shown SH. (1990). The effect of fluorescent humic substances existing in the well water of Blackfoot disease endemic areas in Taiwan on prothrombin time and activated partial thromboplastin time in vitro. Thromb Res 57:747–753.
Mauizio Z, inventor (2002). Treatment of HIV infection with Humic acid. Paris.
Meena H., Pandey H. K., Arya M. C., Ahmed Z. (2010).
Shilajit: a panacea for high-altitude problems. International Journal of Ayurveda Research. 1(1):37–40. doi: 10.4103/0974-7788.59942.
Orsi, M. (2014). Molecular dynamics simulation of humic substances. Chem. Biol. Technol. Agric. 1 (10) doi:10.1186/S40538-014-0010-4.
Pant, Kishor & Singh, B & Thakur, Nagendra. (2012).
Shilajit: A humic matter panacea for cancer. International Journal of Toxicological and Pharmacological Research. 4. 17-25.
Peña-Méndez EM, Havel, J, Patočka J. (2005). Humic substances – compounds of still unknown structure: applications in agriculture, industry, environment, and biomedicine. Appl Biomed. 3:13-24.
Pettit RE (2004). Organic matter, humus, humate, humic acid, fulvic acid and humin: their importance in soil fertility and plant health [Online]. https://humates.com/pdf/ORGANICMATTERPettit.pdf
Piccolo A, Spaccini R, Drosos M, Vinci G, Cozzolino V (2018). The molecular composition of humus carbon: recalcitrance and reactivity in soils. In: Carlos G, Nannipieri P, Hernandez T, editors. The future of soil carbon, its conservation and formation. Cambridge: Academic Press. https://doi.org/10.1016/B978-0-12-811687-6.00004-3.
Piccolo, A. (2002).The supramolecular structure of humic substances: a novel understanding of humus chemistry and implications in soil science. Adv. Agron. 75, 57–134.
Riede UN, Zeck-Kapp G, Freudenberg N, Keller HU, Seubert B. (1991). Humate-induced activation of human granulocytes. Virch- ows Arch B Cell Pathol Incl Mol Pathol 60:27–34.
Sato T, Ose Y, Nagase H, Hayase K. (1987). Mechanism of the desmutagenic effect of humic acid. Mutat Res 176:199–204.
Schepetkin I, Khlebnikov A, Kwon BS. (2002). Medical Drugs From Humus Matter: Focus on Mumie. Drug Dev Res.;57:140–159.
Schepetkin IA, Khlebnikov AI, Ah SY, Woo SB, Jeong CS, Klubachuk ON, Kwon BS (2003). Characterization and Biological Activities of Humic Substances from Mumie. J Agric Food Chem; 51:5245-54.
Schepetkin IA, Xie G, Jutila MA, Quinn MT (2009). “Complement-fixing activity of fulvic acid from
shilajit and other natural sources,” Phytotherapy Research, vol. 23, no. 3, pp. 373–384, 2009.
Schiller F, Klocking R, Wutzler P, Farber I. (1979). Results of an oriented clinical trial of ammonium humate for the local treatment of herpesvirus hominis (HVH) infections. Dermatol Monatsschr 165:505–509.
Schlickewei W, Riede UN, Yu J, Ziechmann W, Kuner EH, Seubert B. (1993). Influence of humate on calcium hydroxyapatite implants. Arch Orthop Trauma Surg 112:275–279.
Shenyuan Yuan, et al. (1993). Application of Fulvic acid and its derivatives in the fields of agriculture and medicine. 1st ed.
Thiel KD, Helbig B, Klocking R, Wutzler P, Sprossig M, Schweizer, H. (1981). Comparison of the in vitro activities of ammonium humate and of enzymically oxidized chlorogenic and caffeic acids against type 1 and type 2 human herpes virus. Pharmazie 36: 50–53.
Thiel KD, Klocking R, Schweizer H, Sprossig M. (1977). In vitro studies of the antiviral activity of ammonium humate against herpes simplex virus type 1 and type 2. Zentralbl Bakteriol A 239:304–321.
van Rensburg CE, Malfeld SCK, Dekker J. (2001). Topical application of oxifulvic acid suppresses the cutaneous immune response in mice. Drug Dev Res 53:29–32.
Vucskits AV, Hullar I, Bersenyi A, Andrasofszky E, Kulcsar M, Szabo J (2010). “Effect of fulvic and humic acids on performance, immune response and thyroid function in rats,” Journal of Animal Physiology and Animal Nutrition, vol. 94, no. 6, pp. 721–728, 2010.
Wang C, Wang Z, Peng A, Hou J, Xin W. (1996). Interaction between fulvic acids of different origins and active oxygen radicals. Sci China C Life Sci 39:267–275.
Wilson E, Rajamanickam GV, Dubey GP, Klose P, Musial F, Saha, F, Rampp Thomas, Michalsen A, Dobos G (2011). Review on
shilajit used in traditional Indian medicine. Journal of ethnopharmacology. 136. 1-9. 10.1016/j.jep.2011.04.033.
Winkler, John; Ghosh, Sanjoy (2018). “Therapeutic Potential of Fulvic Acid in Chronic Inflammatory Diseases and Diabetes,” Journal of Diabetes Research, vol. 2018, Article ID 5391014, 7 pages. https://doi.org/10.1155/2018/5391014.
Yamauchi, Masashige; Katayama, Sadamu; Todoroki, Toshiharu; Watanable, Toshio (1984). “Total synthesis of fulvic acid”. Journal of the Chemical Society, Chemical Communications (23): 1565–6. doi:10.1039/C39840001565.
Yang HL, Tu SC, Lu FJ, Chiu HC. (1994). Plasma protein C activity is enhanced by arsenic but inhibited by fluorescent humic acid associated with Blackfoot disease. Am J Hematol 46:264–269.
Yudina NV, Burkova VN, Pisareva SI, Saratikov AS. (1996). The method for extraction of anti-ulcer remedy. Russian Patent 2055587.
Yudina NV, Pisareva SI, Pinchenkov VI, Loskutova YuV. (1998). Parameters of estimation for biological activity of organic substances of sapropel. Chem Plant Mater 4:33–38.
Zhu L, Chirase N, Ravishankar S (2014). Use of fulvic acid or sodium silicate-based sanitizers to inactivate Listeria monocytogenes, Salmonella Typhimurium and Pseudomonas aeruginosa on food contact surfaces. J Food Saf 34:132–140.